Literature DB >> 24165723

Taking pan-cancer analysis global.

.   

Abstract

Although federated cooperation is politically desirable, uniform data quality and standards are essential and should not be reinvented from scratch. The International Cancer Genome Consortium (ICGC) will do well to start with the data standards of The Cancer Genome Atlas (TCGA) and the Pediatric Cancer Genome Consortium if it is to succeed in genomic analysis across cancer types.

Entities:  

Mesh：

Year:  2013        PMID： 24165723     DOI： 10.1038/ng.2825

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  2 in total

Review 1.  Cancer genome-sequencing study design.

Authors:  Jill C Mwenifumbo; Marco A Marra
Journal:  Nat Rev Genet       Date:  2013-05       Impact factor: 53.242

2.  Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge.

Authors:  Robert M Plenge; Jeffrey D Greenberg; Lara M Mangravite; Jonathan M J Derry; Eli A Stahl; Marieke J H Coenen; Anne Barton; Leonid Padyukov; Lars Klareskog; Peter K Gregersen; Xavier Mariette; Larry W Moreland; S Louis Bridges; Niek de Vries; Tom W J Huizinga; Henk-Jan Guchelaar; Stephen H Friend; Gustavo Stolovitzky
Journal:  Nat Genet       Date:  2013-05       Impact factor: 38.330
  2 in total
  9 in total

1.  The potential of translational bioinformatics approaches for pharmacology research.

Authors:  Lang Li
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

2.  Human germline and pan-cancer variomes and their distinct functional profiles.

Authors:  Yang Pan; Konstantinos Karagiannis; Haichen Zhang; Hayley Dingerdissen; Amirhossein Shamsaddini; Quan Wan; Vahan Simonyan; Raja Mazumder
Journal:  Nucleic Acids Res       Date:  2014-09-17       Impact factor: 16.971

3.  The dream and reality of histology agnostic cancer clinical trials.

Authors:  Denis Lacombe; Susen Burock; Jan Bogaerts; Patrick Schoeffski; Vassilis Golfinopoulos; Roger Stupp
Journal:  Mol Oncol       Date:  2014-09-12       Impact factor: 6.603

4.  Global optimization of somatic variant identification in cancer genomes with a global community challenge.

Authors:  Paul C Boutros; Adam A Margolin; Joshua M Stuart; Adam D Ewing; Kyle Ellrott; Thea C Norman; Kristen K Dang; Yin Hu; Michael R Kellen; Christine Suver; J Christopher Bare; Lincoln D Stein; Paul T Spellman; Gustavo Stolovitzky; Stephen H Friend
Journal:  Nat Genet       Date:  2014-04       Impact factor: 38.330

5.  Toward better benchmarking: challenge-based methods assessment in cancer genomics.

Authors:  Paul C Boutros; Adam A Margolin; Joshua M Stuart; Andrea Califano; Gustavo Stolovitzky
Journal:  Genome Biol       Date:  2014-09-17       Impact factor: 13.583

6.  Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker.

Authors:  Yaqi Yang; Qin Liu; Xiyuan Guo; Qing Yuan; Siji Nian; Pengyuan Kang; Zixi Xu; Lin Li; Yingchun Ye
Journal:  J Oncol       Date:  2022-08-31       Impact factor: 4.501

Review 7.  Immune status for monitoring and treatment of bladder cancer.

Authors:  Shen Pan; Shijie Li; Yunhong Zhan; Xiaonan Chen; Ming Sun; Xuefeng Liu; Bin Wu; Zhenhua Li; Bitian Liu
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

8.  A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment (HIVE).

Authors:  Tsung-Jung Wu; Amirhossein Shamsaddini; Yang Pan; Krista Smith; Daniel J Crichton; Vahan Simonyan; Raja Mazumder
Journal:  Database (Oxford)       Date:  2014-03-25       Impact factor: 3.451

9.  Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancer.

Authors:  Zhanghan Chen; Jie Huang; Yanling Feng; Zehuan Li; Ying Jiang
Journal:  Cancer Med       Date:  2020-08-15       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.